Human Genome Epidemiology Literature Finder
|
Records 1 - 18 (of 18 Records) |
| Query Trace: Disease and AURKA[original query] |
|---|
| Genetic sequence variations of BRCA1-interacting genes AURKA, BAP1, BARD1 and DHX9 in French Canadian families with high risk of breast cancer. Journal of human genetics 2009 Mar 54 (3): 152-61. Guénard Frédéric, Labrie Yvan, Ouellette Geneviève, Beauparlant Charles Joly, Durocher Francine, |
| Functional polymorphisms associated with disease-free survival in resected carcinoma of the esophagus. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2011 Jan 15 (1): 48-56. Boonstra Jurjen J, van Marion Ronald, Tilanus Hugo W, Dinjens Winand N |
| Copy number analysis of 24 oncogenes: MDM4 identified as a putative marker for low recurrence risk in non muscle invasive bladder cancer. International journal of molecular sciences 2014 15 (7): 12458-68. Salvi Samanta, Calistri Daniele, Gurioli Giorgia, Carretta Elisa, Serra Luigi, Gunelli Roberta, Zoli Wainer, Casadio Valenti |
| Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeutics. Human pathology 2014 Aug 45 (8): 1563-71. Jour George, Scarborough John D, Jones Robin L, Loggers Elizabeth, Pollack Seth M, Pritchard Colin C, Hoch Benjamin |
| Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases. JAMA oncology 2016 Dec . Priedigkeit Nolan, Hartmaier Ryan J, Chen Yijing, Vareslija Damir, Basudan Ahmed, Watters Rebecca J, Thomas Roby, Leone Jose P, Lucas Peter C, Bhargava Rohit, Hamilton Ronald L, Chmielecki Juliann, Puhalla Shannon L, Davidson Nancy E, Oesterreich Steffi, Brufsky Adam M, Young Leonie, Lee Adrian |
| Preliminary evidence of polymorphisms of cell cycle regulatory genes and their roles in urinary tract urothelial cancer susceptibility and prognosis in a Taiwan population. Urologic oncology 2017 Jun . Lin Ying-Chu, Hour Tzyh-Chyuan, Tsai Yu-Chieh, Huang Shu-Pin, Wu Wen-Jeng, Chen Chung-Hsin, Pu Yeong-Shiau, Chung Shiu-Dong, Huang Chao-Yu |
| Association of an aurora kinase a (AURKA) gene polymorphism with progression-free survival in patients with advanced urothelial carcinoma treated with the selective aurora kinase a inhibitor alisertib. Investigational new drugs 2017 Feb . Necchi Andrea, Pintarelli Giulia, Raggi Daniele, Giannatempo Patrizia, Colombo Frances |
| Long non-coding RNA taurine-upregulated gene 1 correlates with poor prognosis, induces cell proliferation, and represses cell apoptosis via targeting aurora kinase A in adult acute myeloid leukemia. Annals of hematology 2018 4 97 (8): 1375-1389. Wang Xinfeng, Zhang Lina, Zhao Fan, Xu Ruirong, Jiang Jie, Zhang Chenglu, Liu Hong, Huang Hongmi |
| The Aurora-Kinase A Phe31-Ile polymorphism as possible predictor of response to treatment in head and neck squamous cell carcinoma. Oncotarget 2018 3 9 (16): 12769-12780. Baumann Alexander, Buchberger Anna Maria S, Piontek Guido, Schüttler Dominik, Rudelius Martina, Reiter Rudolf, Gebel Lena, Piendl Gerhard, Brockhoff Gero, Pickhard An |
| Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy. Cancer management and research 2018 10 3801-3808. Liao Yuqian, Liao Yulu, Li Jun, Li Junyu, Fan Ying, Xu Bing |
| Variations in the AURKA Gene: Biomarkers for the Development and Progression of Hepatocellular Carcinoma. International journal of medical sciences 2018 15 (2): 170-175. Wang Bin, Hsu Chin-Jung, Chou Chia-Hsuan, Lee Hsiang-Lin, Chiang Whei-Ling, Su Chen-Ming, Tsai Hsiao-Chi, Yang Shun-Fa, Tang Chih-Hs |
| Novel Prognostic Factors Associated with Cell Cycle Control in Sporadic Medullary Thyroid Cancer Patients. International journal of endocrinology 2019 3 2019 9421079. Pezzani Raffaele, Bertazza Loris, Cavedon Elisabetta, Censi Simona, Manso Jacopo, Watutantrige-Fernando Sara, Pennelli Gianmaria, Galuppini Francesca, Barollo Susi, Mian Cateri |
| Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation. Oncogene 2019 Nov . Jin Ying, Bao Hua, Le Xiuning, Fan Xiaojun, Tang Ming, Shi Xun, Zhao Jun, Yan Junrong, Xu Yang, Quek Kelly, Elamin Yasir Y, Zhang Jianhua, Futreal P Andrew, Wistuba Ignacio I, Heymach John V, Lou Guangyuan, Shao Lan, He Qiong, Lin Chen, Wu Xue, Shao Yang W, Wang Xiaonan, He Jiachen, Chen Yamei, Stebbing Justin, Chen Ming, Zhang Jianjun, Yu Xinm |
| Asynchronous DNA Replication of Biallelically Expressed Genes in Human Peripheral Blood Lymphocytes as a Prognostic Sign of Cancer. Sovremennye tekhnologii v meditsine 2021 10 13 (3): 33-38. Tsepenko V V, Shkavrova T G, Cherkesov V N, Golub E V, Mikhailova G |
| Discovering Genotype Variants in an Infant with VACTERL through Clinical Exome Sequencing: A Support for Personalized Risk Assessment and Disease Prevention. Pediatric reports 2021 1 13 (1): 45-56. Pelizzo Gloria, Chiricosta Luigi, Mazzon Emanuela, Zuccotti Gian Vincenzo, Avanzini Maria Antonietta, Croce Stefania, Lima Mario, Bramanti Placido, Calcaterra Valer |
| WDR62 variants contribute to congenital heart disease by inhibiting cardiomyocyte proliferation. Clinical and translational medicine 2022 Jul 12 (7): e941. Hao Lili, Ma Jing, Wu Feizhen, Ma Xiaojing, Qian Maoxiang, Sheng Wei, Yan Tizhen, Tang Ning, Jiang Xin, Zhang Bowen, Xiao Deyong, Qian Yanyan, Zhang Jin, Jiang Nan, Zhou Wenhao, Chen Weicheng, Ma Duan, Huang Guoyi |
| Clinical and molecular characteristics of estrogen receptor-positive ultralow risk breast cancer tumors identified by the 70-gene signature. International journal of cancer 2022 2 150 (12): 2072-2082. Johansson Annelie, Yu Nancy Y, Iftimi Adina, Tobin Nicholas P, van 't Veer Laura, Nordenskjöld Bo, Benz Christopher C, Fornander Tommy, Perez-Tenorio Gizeh, Stål Olle, Esserman Laura J, Yau Christina, Lindström Linda |
| Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negative breast cancer patients. Frontiers in immunology 2023 6 14 1188030. Oliver Hoffmann, Sebastian Wormland, Ann-Kathrin Bittner, Julian Hölzenbein, Esther Schwich, Sabine Schramm, Hana Rohn, Peter A Horn, Rainer Kimmig, Sabine Kasimir-Bauer, Vera Rebma |
- Page last reviewed:Feb 1, 2024
- Content source: